Annual Total Liabilities
$58.68 M
+$28.90 M+97.01%
December 31, 2023
Summary
- As of February 7, 2025, SNDX annual total liabilities is $58.68 million, with the most recent change of +$28.90 million (+97.01%) on December 31, 2023.
- During the last 3 years, SNDX annual total liabilities has risen by +$10.26 million (+21.19%).
- SNDX annual total liabilities is now at all-time high.
Performance
SNDX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$59.38 M
+$16.77 M+39.36%
September 30, 2024
Summary
- As of February 7, 2025, SNDX quarterly total liabilities is $59.38 million, with the most recent change of +$16.77 million (+39.36%) on September 30, 2024.
- Over the past year, SNDX quarterly total liabilities has increased by +$19.34 million (+48.31%).
- SNDX quarterly total liabilities is now at all-time high.
Performance
SNDX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
SNDX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +97.0% | +48.3% |
| 3 y3 years | +21.2% | +24.6% |
| 5 y5 years | +90.0% | +24.6% |
SNDX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +97.0% | at high | +175.1% |
| 5 y | 5-year | at high | +97.0% | at high | +175.1% |
| alltime | all time | at high | +1025.9% | at high | +1177.0% |
Syndax Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $59.38 M(+39.4%) |
| Jun 2024 | - | $42.61 M(-16.7%) |
| Mar 2024 | - | $51.14 M(-12.9%) |
| Dec 2023 | $58.68 M(+97.0%) | $58.68 M(+46.6%) |
| Sep 2023 | - | $40.04 M(+27.9%) |
| Jun 2023 | - | $31.30 M(+28.7%) |
| Mar 2023 | - | $24.32 M(-18.4%) |
| Dec 2022 | $29.79 M(-27.9%) | $29.79 M(+38.0%) |
| Sep 2022 | - | $21.59 M(-51.5%) |
| Jun 2022 | - | $44.50 M(-6.7%) |
| Mar 2022 | - | $47.67 M(+15.5%) |
| Dec 2021 | $41.29 M(-14.7%) | $41.29 M(+2.0%) |
| Sep 2021 | - | $40.50 M(-16.5%) |
| Jun 2021 | - | $48.50 M(-5.8%) |
| Mar 2021 | - | $51.47 M(+6.3%) |
| Dec 2020 | $48.42 M(+51.7%) | $48.42 M(+2.3%) |
| Sep 2020 | - | $47.33 M(+5.2%) |
| Jun 2020 | - | $44.98 M(-12.9%) |
| Mar 2020 | - | $51.65 M(+61.8%) |
| Dec 2019 | $31.93 M | $31.93 M(-1.3%) |
| Sep 2019 | - | $32.34 M(+0.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $32.12 M(+4.4%) |
| Mar 2019 | - | $30.77 M(-0.4%) |
| Dec 2018 | $30.89 M(-6.0%) | $30.89 M(-4.0%) |
| Sep 2018 | - | $32.19 M(-8.1%) |
| Jun 2018 | - | $35.02 M(+6.1%) |
| Mar 2018 | - | $33.01 M(+0.4%) |
| Dec 2017 | $32.87 M(+32.1%) | $32.87 M(+18.3%) |
| Sep 2017 | - | $27.78 M(+9.7%) |
| Jun 2017 | - | $25.33 M(+1.1%) |
| Mar 2017 | - | $25.05 M(+0.7%) |
| Dec 2016 | $24.87 M(+7.2%) | $24.87 M(+4.1%) |
| Sep 2016 | - | $23.89 M(+10.5%) |
| Jun 2016 | - | $21.61 M(-3.6%) |
| Mar 2016 | - | $22.41 M(-3.4%) |
| Dec 2015 | $23.20 M(+25.2%) | $23.20 M(-27.7%) |
| Sep 2015 | - | $32.08 M(+73.1%) |
| Dec 2014 | $18.53 M(+255.6%) | $18.53 M(+24.3%) |
| Sep 2014 | - | $14.90 M(+178.6%) |
| Jun 2014 | - | $5.35 M(+15.1%) |
| Mar 2014 | - | $4.65 M(-10.8%) |
| Dec 2013 | $5.21 M(-83.1%) | $5.21 M |
| Dec 2012 | $30.80 M | - |
FAQ
- What is Syndax Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Syndax Pharmaceuticals?
- What is Syndax Pharmaceuticals annual total liabilities year-on-year change?
- What is Syndax Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Syndax Pharmaceuticals?
- What is Syndax Pharmaceuticals quarterly total liabilities year-on-year change?
What is Syndax Pharmaceuticals annual total liabilities?
The current annual total liabilities of SNDX is $58.68 M
What is the all time high annual total liabilities for Syndax Pharmaceuticals?
Syndax Pharmaceuticals all-time high annual total liabilities is $58.68 M
What is Syndax Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, SNDX annual total liabilities has changed by +$28.90 M (+97.01%)
What is Syndax Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of SNDX is $59.38 M
What is the all time high quarterly total liabilities for Syndax Pharmaceuticals?
Syndax Pharmaceuticals all-time high quarterly total liabilities is $59.38 M
What is Syndax Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, SNDX quarterly total liabilities has changed by +$19.34 M (+48.31%)